Australia's most trusted source of pharma news
Tuesday, 26 February 2019
Lost Your Access?
Blackmores CEO steps down
Richard Henfrey goes after just 18 months at the helm.
Kicks off 2019 with NRL naming rights goal.
Pitches for quick trial to avoid competing damages claim.
Tecentriq looks for class first
Roche seeks breast cancer listing for its I-O star.
Roche buys into gene therapy
$4.8b for genetic pipeline while local biotech attracts $180m.
MA looking for managers
Compliance and research roles open up at peak body.
Novartis boosts CAR-T team
Is it in final preparations for MSAC launch?
Multimillion blow to Sandoz
Generic must pay Lundbeck for Lexapro patent breach.
A final PBS win as Shire boss moves to merged business.
Which companies fell outside the listing norm in 2017-18?
Amgen names interim boss
Local exec steps in as My Linh Kha fills Chinese gap.
Teva exec to head up AusCann
Pharma veteran says medicinal cannabis has big future.
Sanofi loses Lantus battle
Appeal over biosim Semglee knocked down by court.
Sponsors hail new cancer listings
AbbVie, MSD welcome additional PBS indications.
Gender equity citations for pharma
Companies singled out as employers of choice.
Approval for generic lung cancer competitor.
AbbVie advances RA drug
Uses priority review voucher for upadacitinib.
Top of the Hill
Why a story told well is pharma's most valuable message.
Events & Conferences
Â© 2003 - 2019 Lush Media
Jolly Good Design